C
Celltex Therapeutics
Adult stem cell laboratory that operates a bank to store adult stem cells for medical treatments
About Celltex Therapeutics
Celltex Therapeutics Corporation specializes in the banking and therapy of mesenchymal stem cells (MSCs) to address future health emergencies and regenerative treatments. Operating in the regenerative medicine market, Celltex serves clients who are looking to preserve their younger, healthier stem cells for potential future use. The business model revolves around a four-step process: extraction, banking, expansion, and therapy of MSCs. Clients typically include individuals concerned about aging, chronic pain, and other medical conditions that may benefit from stem cell therapy. Celltex generates revenue through the initial extraction and banking fees, as well as ongoing storage and therapy services. The company also organizes seminars to educate potential clients and share success stories.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- Houston, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Celltex Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Celltex Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.